Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
Authors:
- Souvik SenSSSouvik Sen
- Katherine Willett DahlbergKDKatherine Willett Dahlberg
Open Access
- 1 December 2014
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 348 (6) , 513-521
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Executive Summary: Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJACC, 2011
- Prevention of Cardioembolic StrokeNeurotherapeutics, 2011
- Should anticoagulation be resumed after intracerebral hemorrhage?Cleveland Clinic Journal of Medicine, 2010
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Barriers to the Use of Anticoagulation for Nonvalvular Atrial FibrillationStroke, 2008
- Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleedingCanadian Medical Association Journal, 2007
- Bleeding Complications With Warfarin UseArchives of internal medicine (1960), 2007
- Translating the Results of Randomized Trials into Clinical PracticeStroke, 2006
- Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial FibrillationStroke, 2006